Publication of trial sites in result reports of clinical trials pursuant to Section 42b German Medicinal Products Act (Arzneimittelgesetz, AMG) – Amended version of 19 June 2020 – Updated joint information from the Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) and the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines (Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel, PEI)